Chapter 1187 Hongju Gene Is Established

After leaving the Dong family, Shi Lei went to the imperial capital again and contacted the four companies in the imperial capital.

Of course, it was no longer limited to the level of Ma Yuan and Zou Ziqi, but he met directly with the presidents of the four companies.

He still put the test reports in front of these people. These people behaved in the same way as Dong Yi and Xu Jing. While saying that they would immediately stop contacting the consortium, they were secretly glad that this project was fortunately not through their hands and successfully cooperated with Qixuan, otherwise, it would be a big deal.

Finally, Shi Lei contacted the old man directly, met him with the test report, and told him the seriousness of the matter.

The old man was also shocked and expressed his full gratitude to Shi Lei.

At this point, Shi Lei no longer needed to follow up... No matter how far the consortium pushed this project, under the absolute administrative order, there would be no possibility of taking root.

Even this consortium will be blacklisted by the Chinese government. Not to mention this project, I am afraid that in the future, as long as they participate in any project, the government will seriously consider it, and even directly refuse to cooperate with this consortium in any form.

As for the Xu family, regardless of whether they can find Xu Zhida or get the original contract of the equity, they directly announced that they would transfer these shares to Dong Chiqing, leaving only the one point that originally belonged to them.

Although this operation is actually in conflict with the law, no matter where Xu Zhida will go in the end, as long as he does not intend to completely break with his family, this statement and the re-signed document will be valid.

Of course, the Xu family also took a series of preventive measures, such as authorizing his father Xu Jing to deal with Qixuan's shares in the name of Xu Zhida. The process is certainly not completely legal, but to some extent, it is also legally effective.

The hidden danger seems to have been eliminated, but Xu Zhida's whereabouts are still unknown, which means that the whereabouts of the ferryman are still unknown.

But Shi Lei can't always focus on these things. He has more important things to deal with.

Yao Er has helped Ding Yu complete the company registration and other matters in Hong Kong Island, and at Ding Yu's invitation, he became the CEO of the company called Hong Kong Gene.

The company has been quietly established, and has reached a cooperation agreement with a hospital in Hong Kong Island to launch the first gene plan.

As one of the shareholders who will soon own 11% of the company's shares, Shi Lei will naturally attend the company's inauguration ceremony.

Due to the operation during this period, Hong Kong Gene has not been officially established, but it has already made a name for itself. The cooperating hospital has also had successful cases. Through genetic surgery, two patients who were declared vegetative have been revived.

This has attracted worldwide attention. Hong Kong Island attaches great importance to this. Even the Chief Executive's Office has contacted Yao Er and said that the Chief Executive will personally attend the inauguration ceremony of Hong Kong Gene.

Investment companies around the world have flocked to it. After their careful investigation, they are convinced of Hong Kong Gene's achievements in genetic engineering.

The investment intentions of these investment companies have obviously made more people believe in the strength of Hong Kong Gene. This is an excellent virtuous cycle, which naturally makes Hong Kong Gene more attractive to capital.

Although Hong Kong Gene has not been officially established, fund organizations have already made market valuations for Hong Kong Gene.

It did not disappoint Shi Lei's expectations, and it was even higher than Ding Yu's original imagination, which made him unbelievable.

Since Hong Kong Gene has not been officially established, the valuation of those funds has only remained in the internal stage and has not been announced to the outside world. However, after communication and investigation, Yao Er learned that among the three funds he investigated, the lowest valuation of Hong Kong Gene has reached 2 billion, and it is still a valuation in US dollars.

This means that as long as Hong Kong Gene is officially established and uses the last funds on hand to promote the business model, then the valuation of Hong Kong Gene will soon exceed 5 billion US dollars.

A company that has not yet been fully established has a valuation of billions of US dollars. If the valuation of Qixuan has soared to a jaw-dropping level in the past year, then the valuation of Gangju Gene has obviously been at the top of the mountain since its birth.

You know, after more than a year of development, Qixuan's valuation is only about 3 billion US dollars, but Gangju Gene already has a base of 2 billion US dollars.

After Shi Lei arrived in Hong Kong Island, Yao Er was very busy, but he still went to the border to pick up Shi Lei in person.

Ding Yu also came in person after Shi Lei arrived at the hotel, even though he is now a wealthy man with a net worth of more than 1 billion US dollars.

Of course, all the shares of Gangju Gene belong to Ding Yu's research institute. According to Ding Yu's design, 40% of these shares are for him to share with other scientists.

Of course, those scientists cannot take all the shares directly. They can only take 35%, and the remaining five points will be left for managers who will join the company in the future.

Although only five points are left in total, this is already an extremely terrifying fortune.

According to the current lowest valuation of Gangju Gene, five points of shares have reached 100 million US dollars.

With the development of the company, the company's valuation and the market value after listing in the future are likely to exceed 30 billion or even higher. Then, these five points will be worth at least more than a billion US dollars. It seems that there are not many shares, but in fact, their gold content is no less than that of other startups.

Ding Yu holds 60% of the shares.

Of course, there are 11 points to be paid to Shi Lei, but Ding Yu still holds 49% of the shares.

2 billion, 49%, that is close to 1 billion.

But this is still the lowest valuation. The shares in Ding Yu's hands are worth more than 1 billion US dollars at this moment, and there is no problem at all.

However, he has made a promise that before Hongju Gene goes public, it will only do four rounds of financing at most, and each round will sell 10%, and the transfer of shares in these four rounds of financing will be borne by him personally.

In other words, when Hongju Gene goes public in the future, he will only keep nine points of shares in his hands.

But even so, these nine points, with the current attractiveness of Hongju Gene to the capital market, will be worth at least 30 billion when it goes public, and Ding Yu can almost be said to have a net worth of at least 3 billion US dollars in the future.

Of course, the one who will benefit the most from this will be Shi Lei, because Shi Lei's shares will be as high as 11%.

Ding Yu came here with a share transfer agreement, which was drafted by Yao Er and the lawyer, and of course there will be no problems. As long as Shi Lei signs his name on it, he can take away 11% of the shares.

"Mr. Shi, I will live up to your trust and finally fulfill my original promise. This is the share transfer agreement, please take a look."

Shi Lei nodded and said with a smile: "I have currently given you a total investment of 63 million RMB. According to the original agreement of 11 million US dollars, at the current exchange rate, I still need to give you more than 8 million."

4